No Detail Found!

Bioinformatics Analysis Screened and Identi ed Key Genes as Potential Biomarkers for Progression of Lung Cancer

Author(s)
Ying Chen Department of Critical Care Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China
Xing-Kai Wang Department of Orthopedics, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China
Yan Wang Department of Respiratory Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China
Jun-Wei Zong Department of Orthopedics / Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province,China
Shou-Yu Wang Department of Orthopedics / Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province,China
Xian-Yao Wan Department of Critical Care Medicine / Respiratory Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian,Liaoning Province, China
Abstract
Objective: To screen and identify key genes as potential biomarkers of lung cancer using bioinformatics analysis. Study Design: Observational study. Place and Duration of Study: Department of Critical Care Medicine, the First A liated Hospital of Dalian Medical University, Dalian, Liaoning Province, China, from August 2018 to April 2021. Methodology: Independent microarray datasets (GSE85841 and GSE118370) were downloaded from the Gene Expression Omnibus (GEO) database and the di erentially expressed genes (DEGs) were screened using GEO2R. Cytohubba was employed to identify the hub genes. Cellular component analysis, hierarchical clustering, and survival analyses of hub genes were performed via BiNGO, UCSC, and cBioPorta. A series of analyses of FGF2 and PIK3R1 were conducted using Oncomine. Results: A total of 463 DEGs were identi ed and 11 hub genes were determined. BDNF, FGF2, JAK2, NCAM1, CAV1, TJP1, and PIK3R1 may a ect the survival probability and life expectancy of lung cancer patients, but the p-values were not statistically signi cant. FGF2 and PIK3R1 had the highest node degrees, 40 and 32 respectively. The expression of FGF2 and PIK3R1 were signi cantly lower in the 4 lung cancer data sets compared with non-lung cancer tissues. And the low expression of FGF2 and PIK3R1 is related to tumor grades, family history of cancer, multiple tumors present, and prior therapy of lung cancer. Conclusion: Evaluation of FGF2 and PIK3R1 as potential biomarkers can contribute to the subsequetnhteoretical analysis of potential molecular mechanisms and development of lung cancer, so that the diagnosis of lung cancer may be more accurate, and it is possible to provide therapeutic and prognostic medicine targets.
Publication Details
Page(s) 712-721
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 6, Year: 2022

Request the full text from PASTIC

Keywords
Biomarkers, Lung neoplasms, Di erentially expressed genes, Bioinformatical analysis, Microarray analysis
0

Citations

0

Downloads

158

Views